Standalone & Consolidated Financial Results, Limited Review Report for June 30, 2016
Sicagen India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 2016 Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Sicagen India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Board Meeting Intimation for Results
Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company has been scheduled to be held on Wednesday, the August 03, 2016 at 10.45 a.m. inter alia, to consider & approve the unaudited financial results (both standalone & consolidated results) of the Company for the quarter ended June 30, 2016. Shareholding for the Period Ended June 30, 2016
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Outcome of Board Meeting
Sicagen India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2016, have appointed Mr. R. Achuthan as Company Secretary and Compliance Officer with immediate effect in the place of Mr. G. Arumozhi who resigned from the services of the Company. Board recommends Dividend
Sicagen India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2016, inter alia, have recommended equity dividend @ 6% (60 paise per share) for the FY 2015-16, subject to the approval of shareholders at the ensuing Annual General Meeting. Standalone & Consolidated Financial Results, Form A, Form B, Auditors Report for March 31, 2016
Sicagen India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form A for the period ended March 31, 20164. Consolidated Form B for the period ended March 31, 20165. Standalone Auditors Report for the period ended March 31, 20166. Consolidated Auditors Report for the period ended March 31, 2016 Board to consider Dividend
Sicagen India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 25, 2016, inter alia, to consider the following:1. Audited Annual Accounts of the Company for the year ended March 31, 2016.2. Audited Financial Results (Standalone & Consolidated Results) for the quarter and year ended March 31, 2016.3. Recommendation of equity dividend if any considered, for the year ended March 31, 2016. Shareholding for the Period Ended March 31, 2016
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here